and the Food and Drug Administration (FDA) while a lawsuit challenging the administration’s decision to remove it is pending.
A plan for the US Food and Drug Administration to propose banning formaldehyde and certain formaldehyde-releasing chemicals ...
FDA announces recall affecting millions of Dunkin' baked goods including beloved Munchkins, donuts, and fritters - here's ...
Biohaven stock hurdled its 50-day and 200-day lines Tuesday after the FDA granted its SCA treatment a speedier review time.
Travere Therapeutics reached an agreement Tuesday on what data the FDA would require to approve its drug for a kidney disease.
There’s another recall to be aware of right now, and it involves nose spray. NeilMed Pharmaceuticals Inc., the manufacturer of NasoGel Spray, has issued an international recall of 89,312 of its sprays ...
Gottlieb, who led the agency during the first Trump presidency, supports a reversion to an earlier interpretation of the 21st Century Cures Act.
Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), today announced that the US Food and Drug Administration (FDA) has ...
The future of formaldehyde in hair straighteners remains uncertain as the FDA has proposed a ban on the chemical, which is commonly used in these products. Formaldehyde is a known carcinogen, raising ...
Only time will tell what is next in the landscape of tobacco and nicotine regulation from the White House and the FDA.
Regeneron, which is seeking FDA approval of linvoseltamab for adults with relapsed/refractory multiple myeloma that has progressed after at least three prior therapies, said the agency set a new ...
Travere Therapeutics shares rose sharply in early trading Tuesday after the biopharmaceutical company said it plans to seek expanded Food and Drug Administration approval of its kidney-disease drug ...